In vitro proliferative and differentiating characteristics of CD133+ and CD34+ cord blood cells in the presence of thrombopoietin (TPO) or erythropoietin (EPO): Potential implications for hematopoietic cell transplantation

Leukemia Research

Volumn 27, Issue 12, 2003, Pages 1143-1151

  Dimitriou, Helen ^a   Vorgia, Pelagia ^a   Stiakaki, Eftichia ^a   Mavroudis, Dimitris ^a   Markaki, Erasmia Athina ^a   Koumantakis, Eugene ^a   Kalmanti, Maria ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

CD133+; CD34+; Cord blood; Erythropoietin; Ex vivo expansion; Thrombopoietin

Indexed keywords

ANTIGEN; CD133 ANTIGEN; CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; THROMBOPOIETIN; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; ARTICLE; BLOOD CELL; BURST FORMING UNIT E; CELL DIFFERENTIATION; CELL FRACTIONATION; CELL MATURATION; CELL POPULATION; CELL PROLIFERATION; CLONOGENIC ASSAY; COLONY FORMING UNIT GM; COMPARATIVE STUDY; CONTROLLED STUDY; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; LIQUID CULTURE; PARAMETER; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

EID: 0043063964     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(03)00107-3     Document Type: Article

References (32)

1. + cells from human umbilical cord blood. Br J Hematol 2000;108:793-800.
2. McNiece I., Briddell R. Ex vivo expansion of hematopoietic progenitor cells and mature cells. Exp. Hematol. 29:2001;3-11.
3. Civin C.I., Loken M.R. Cell surface antigens on human marrow cells: dissection of hematopoietic development using monoclonal antibodies and multiparameter flow cytometry. Int. J. Cell Cloning. 5:1987;267-288.
4. Dimitriou H., Matsouka C., Perdikoyanni C., Stiakaki E., Bolonaki I., Lydaki E.et al. Phenotypic characteristics of cord blood hemopoietic cells. Leuk. Res. 22:1998;755-758.
5. Civin C.I., Gore S.D. Antigenic analysis of hematopoiesis: a review. J. Hematother. 2:1993;137-144.
6. Sutherland D., Keating A. The CD34 antigen: structure, biology and potential clinical applications. J. Hematother. 1:1992;115-129.
7. - cells in cord blood and bone marrow. Blood. 86:1995;3745-3753.
8. Yin A.H., Miraglia S., Zanjani E.D., Almeida-Porada G., Ogawa M., Leary A.G.et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood. 90:1997;5002-5012.
9. Miraglia S., Godfrey W., Yin A.H., Atkins K., Warnke R., Holden J.T.et al. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization and molecular cloning. Blood. 90:1997;5013-5021.
10. Testa U., Torelli G.F., Riccioni R., Muta A.O., Militi S., Annino L.et al. Human acute stem cell leukemia with multilineage differentiation potential via cascade activation of growth factor receptors. Blood. 99:2002;4634-4637.
11. + peripheral blood progenitor cells from patients with CML. Leukemia. 13:1999;1466-1467.
12. + leukemic line: MUTZ-2. Blood. 92:1998;4485-4487.
13. Horn P.A., Tesch H., Staib P., Kube D., Diehl V., Voliotis D. Expression of AC133, a novel hematopoietic precursor antigen, on acute myeloid leukemia cells. Blood. 93:1999;1435-1437.
14. Yagi M., Ritchie K.A., Sitnicka E., Storey C., Roth G.J., Bartelmez S. Sustained ex vivo expansion of hematopoietic stem cells mediated by thrombopoietin. Proc. Natl. Acad. Sci. U.S.A. 96:1999;8126-8131.
15. Ohmizono Y., Sakabe H., Kimura T., Tanimukai S., Matsumura T., Miyazaki H.et al. Thrombopoietin augments ex vivo expansion of human cord blood-derived hematopoietic progenitors in combination with stem cell factor and flt3 ligand. Leukemia. 11:1997;524-530.
16. Geddis A.E., Linden H.M., Kaushansky K. Thrombopoietin: a pan-hematopoietic cytokine. Cytokine Growth Factor Rev. 13:2002;61-73.
17. Wyrsch A., dalle Carbonare V., Jansen W., Chklovskaia E., Nissen C., Surbek D.et al. Umbilical cord blood from preterm human fetuses is rich in committed and primitive hematopoietic progenitors with high proliferative and self-renewal capacity. Exp. Hematol. 27:1999;1338-1345.
18. + umbilical cord blood progenitors demonstrate rapid self-renewal and low apoptosis. Br. J. Haematol. 119:2002;516-524.
19. + cell selection for ex vivo expansion of hematopoietic stem cells. J. Hematother. Stem Cell Res. 10:2001;273-281.
20. + cells in collagen and liquid culture media. J. Hematother. Stem Cell Res. 10:2001;391-403.
21. Denning-Kendall P.A., Donaldson C., Nicol A., Bradley B., Hows J. Optimal processing of human umbilical cord blood for clinical banking. Exp. Hematol. 24:1996;1394-1401.
22. Coutinho LH, Gilleece MH, de Wynter EA, Will A, Testa NG. Clonal and long-term cultures using human bone marrow. In: Testa NG, Molineux G, editors. Hemopoiesis: a practical approach. Oxford: Oxford University Press; 1993. p. 75-106.
23. Gordon M.Y., Marley S.B., Lewis J.L., Davidson R.J., Nguyen D.X., Grand F.H.et al. Treatment with interferon-α preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors (CFU-GM) from patients with chronic myeloid leukemia but spares normal CFU-GM. J. Clin. Invest. 102:1998;710-715.
24. Marley S.B., Lewis J.L., Davidson R.J., Roberts I.A., Dokal I., Goldman J.M.et al. Evidence for a continuous decline in haemopoietic cell function from birth: application to evaluating bone marrow failure in children. Br. J. Haematol. 106:1999;162-166.
25. Marley S.B., Davidson R.J., Goldman J.M., Gordon M.Y. Combination of interferon-α with either Ara-C or ATRA in vitro reduces the selective action of interferon against CML CFU-GM. Leukemia. 14:2000;1396-1400.
26. Snedecor GW, Cochran W. Statistical methods. 6th ed. Iowa, USA: Iowa State University Press; 1984.
27. Ball E.D. Ex vivo purging and cell expansion. J. Hematother. Stem Cell Res. 8:1999;457-458.
28. Socie G., Cayuela J.M., Raynal B., Esperou H., Fund X., Raffoux C.et al. Influence of CD34 cell selection on the incidence of mixed chimaerism and minimal residual disease after allogeneic unrelated donor transplantation. Leukemia. 12:1998;1440-1446.
29. Eaton D.L., de Sauvage F.J. Thrombopoietin: the primary regulator of megakaryocytopoiesis and thrombopoiesis. Exp. Hematol. 25:1997;1-7.
30. + cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors. Stem Cells. 16:1998;387-396.
31. Hao Q.L., Thiemann F.T., Petersen D., Smogorzewska E.M., Crooks G.M. Extended long-term culture reveals a highly quiescent and primitive human hematopoietic progenitor population. Blood. 88:1996;3306-3313.
32. Talvensaari K., Clave E., Douay C., Rabian C., Garderet L., Busson M.et al. A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation. Blood. 99:2002;1458-1464.